Stay updated on ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Sign up to get notified when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T15:28:02.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH website changes and says that “Super Intelligence” may appear in place of “Artificial Intelligence” during the transition. The site revision advances from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T14:45:37.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-07T14:36:47.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error for the study record, with HTML indicating a 403 message and a link back to Home. This indicates the study record is currently inaccessible on ClinicalTrials.gov.
    Difference
    21%
    Check dated 2026-09-23T19:20:54.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    A new Revision: v3.7.0 has been added and Revision: v3.6.6 has been removed, indicating an update to the ACTT study's documentation on the page. This update reflects revised protocol details and associated study documentation.
    Difference
    0.0%
    Check dated 2026-09-16T22:02:57.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page revision label updated from v3.6.5 to v3.6.6, indicating a new deployment of the study details page. This likely reflects minor fixes or updates to the page rendering or metadata without altering the study information presented to users.
    Difference
    0.0%
    Check dated 2026-09-02T19:15:59.000Z thumbnail image

Stay in the know with updates to ACTT: Remdesivir for Severe COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ACTT: Remdesivir for Severe COVID-19 Clinical Trial page.